Alpha Teknova, Inc. engages in the manufacture of cell culture media and supplements. The company is headquartered in Hollister, California. The company went IPO on 2021-06-25. The company offers two primary product categories, which include lab essentials and clinical solutions. The company also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The firm offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. The company supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.
TKNO'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
Alpha Teknova Inc'in en son EPS'si $-0.09 olup, $-0.09 beklentilerini kazanmamak.
Alpha Teknova Inc TKNO'ün son çeyrekteki geliri nasıl performans gösterdi?
Alpha Teknova Inc'in son çeyrek geliri $-0.09
Alpha Teknova Inc'in gelir tahmini nedir?
8 Wall Street analistine göre, Alpha Teknova Inc'in gelir tahmini $10.97M ile $9.5M arasında değişmektedir.
Alpha Teknova Inc'in kazanç kalite puanı nedir?
Alpha Teknova Inc'in kazanç kalite puanı B+/46.90808'dir. Puan, karlılık, büyüme, nakit üretimi ve sermaye tahsisi ile kaldıraç olmak üzere dört boyuta dayanır.
Alpha Teknova Inc kazançlarını ne zaman rapor eder?
Alpha Teknova Inc'in bir sonraki kazanç raporu 2026-05-27'te bekleniyor